Engerix-B Pediatric Interactions
There are 280 drugs known to interact with Engerix-B Pediatric (hepatitis b pediatric vaccine), along with 2 disease interactions. Of the total drug interactions, 1 is major, 277 are moderate, and 2 are minor.
- View all 280 medications that may interact with Engerix-B Pediatric
- View Engerix-B Pediatric disease interactions (2)
Most frequently checked interactions
View interaction reports for Engerix-B Pediatric (hepatitis b pediatric vaccine) and the medicines listed below.
- ActHIB (haemophilus b conjugate (prp-t) vaccine)
- Adakveo (crizanlizumab)
- Caprelsa (vandetanib)
- chloral hydrate
- Daptacel (DTaP) (diphtheria and tetanus toxoids / pertussis, acellular)
- deserpidine / methyclothiazide
- dextromethorphan / guaifenesin / phenylpropanolamine
- Droxia (hydroxyurea)
- elbasvir / grazoprevir
- enalapril
- Evrysdi (risdiplam)
- fosinopril
- Gardasil 9 (human papillomavirus vaccine)
- Gazyva (obinutuzumab)
- Givlaari (givosiran)
- goldenseal
- Havrix Pediatric (hepatitis a pediatric vaccine)
- Hiberix (haemophilus b conjugate (prp-t) vaccine)
- idelalisib
- Imbruvica (ibrutinib)
- imiquimod topical
- Infanrix (DTaP) (diphtheria and tetanus toxoids / pertussis, acellular)
- Ingrezza (valbenazine)
- Invirase (saquinavir)
- Ipol (poliovirus vaccine, inactivated)
- Kinrix (diphtheria toxoid / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid)
- Leukeran (chlorambucil)
- Liquid PedvaxHIB (haemophilus b conjugate (prp-omp) vaccine)
- Luvox (fluvoxamine)
- M-M-R II (measles virus vaccine / mumps virus vaccine / rubella virus vaccine)
Engerix-B Pediatric disease interactions
There are 2 disease interactions with Engerix-B Pediatric (hepatitis b pediatric vaccine) which include:
More about Engerix-B Pediatric (hepatitis b pediatric vaccine)
- Engerix-B Pediatric consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: viral vaccines
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.